ALS Center, IRCCS Istituto Auxologico Italiano

University of Milan Medical School

The ALS Centre is a referral institution in Italy for the diagnosis and care of patients affected by ALS and other motor neuron diseases, offering a multidisciplinary team, clinical trials, genetic diagnosis and biomarker investigations.

MilanMedicalSchool_Logo
University of Milan Medical School

We offer adequate clinical diagnosis with the support of a multidisciplinary team and a centre for clinical trials. Research in the Laboratory of Neuroscience mainly focuses on genetics of ALS, ALS disease mechanisms using in vitro cell models, iPSCs as a bioassay of clinical relevance, and biomarker identification. We have made a big effort to develop eye tracking and BCI technologies for the definition of neuropsychological changes in people with ALS. The Milan ALS Centre has been audited by FDA in 1997 for a clinical trial.

Contact
Location
International Medical School, University of Milan, Milan, Metropolitan City of Milan, Italy

Our Specialists

Vincenzo Silani

Professor of Neurology and Chairman

Vincenzo Silani is Professor of Neurology, Director of the Department of Neurology-Stroke […]

Vincenzo Silani
Current trials
Completed
Phase iii

PHOENIX trial

Industry trial
Amylyx Pharmaceuticals Inc is conducting a phase 3 trial to determine the safety and efficacy of their compound 'AMX0035' for the treatment of ALS.
Read more
Completed
Phase iii

ADORE trial

Industry trial
Ferrer is conducting a phase 3 trial to evaluate the safety and potential efficacy of an investigational drug for people with Amyotrophic Lateral Sclerosis (ALS).
Read more
Completed
Phase iii

TUDCA-ALS

Investigator initiated trial
This trial will evaluate the efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment for people with ALS.
Read more